title: Angiotensin-Converting Enzyme Inhibitors vs. Angiotensin Receptor Blockers.
authors.affiliation: University of Toronto Faculty of Medicine, Department of Family and Community Medicine, Toronto, Canada.
authors.forename: Bachir
authors.initials: B
authors.lastname: Tazkarji
authors.affiliation: University of Toronto Faculty of Medicine, Department of Family and Community Medicine, Toronto, Canada.
authors.forename: Ambika
authors.initials: A
authors.lastname: Ganeshamoorthy
authors.affiliation: University of Florida Health Science Center Libraries, Gainesville, FL, USA.
authors.forename: Beth
authors.initials: B
authors.lastname: Auten
mesh_terms: D057911:Angiotensin Receptor Antagonists / Q000009:adverse effects / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D000959:Antihypertensive Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000401:mortality; D016896:Treatment Outcome
chemical_list: D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors; D000959:Antihypertensive Agents